| Similar Articles |
|---|
 |
American Family Physician
March 1, 2006
Satpathy et al. |
Diagnosis and Management of Diastolic Dysfunction and Heart Failure With early diagnosis and proper management the prognosis of diastolic dysfunction is more favorable than that of systolic dysfunction. Distinguishing diastolic from systolic heart failure is essential because the optimal therapy for one may aggravate the other.   |
American Family Physician
December 1, 2004
Steven A. Dosh |
Diagnosis of Heart Failure in Adults The evaluation of symptomatic patients with suspected heart failure is directed at confirming the diagnosis, determining the cause, identifying concomitant illnesses, establishing the severity of heart failure, and guiding therapy. |
American Family Physician
June 1, 2004
Gutierrez & Blanchard |
Diastolic Heart Failure: Challenges of Diagnosis and Treatment The outcomes of ongoing clinical trials may provide much-needed information about diastolic heart failure to move from intuitive treatment to therapy based on evidence that matters: decreased morbidity and mortality and improved quality of life. |
American Family Physician
November 15, 2005
William E. Cayley |
Diagnosing the Cause of Chest Pain Distinguishing between serious and benign causes of chest pain is imperative, and diagnostic and prognostic questions are important in making this determination. |
American Family Physician
April 15, 2005
Karnani, Reisfield & Wilson |
Evaluation of Chronic Dyspnea Chronic dyspnea is defined as dyspnea lasting more than one month. Information is presented on diagnosis, assessment and treatment for chronic dyspnea. |
American Family Physician
September 1, 2001
William E. Chavey |
Guideline for the Management of Heart Failure Caused by Systolic Dysfunction Part I: Guideline development, etiology and diagnosis... |
Managed Care
July 2004
Thomas Morrow |
Nesiritide Speeds Recovery Time For Heart Failure Patients As clinicians recognize heart failure's neurohormonal component, a biologic agent may prove better than the small molecules. |
Nursing
June 2011
Daniel A. Hussar |
New Drugs 2011: Part 2 In this article, you'll learn about seven recently approved drugs, including: fingolimod hydrochloride, an oral drug indicated to treat patients with relapsing forms of multiple sclerosis. |
Nursing
February 2010
Daniel A. Hussar |
New Drugs 2010, PART 1 In this article, you'll learn about 16 new drugs. |
Nursing
June 2010
Daniel A. Hussar |
New drugs 2010, part 2 In this article, you'll learn about 14 recently marketed new drugs. |
Pharmaceutical Executive
November 1, 2012
Sue Barrowcliffe |
Real World Insights Commercial teams as well as patients can benefit from managed access programs, which are designed to provide access to medicines outside of the clinical and commercial setting, for patients who have no other available treatment options. |
The Motley Fool
January 3, 2011
Brian Orelli |
Clinical Trial Results Fail to Inspire Inspire Pharma gets cut in half after a cystic fibrosis trial failure. |
